• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Continuous Glucose Monitoring Devices Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Medical Devices
  • 96 Pages
  • Report Code: 24LS-8630
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Ctinuous Glucose Mitoring Devices -MARKET ADVISORY SERVICES

This report focuses on the global Continuous Glucose Monitoring Devices status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Continuous Glucose Monitoring Devices development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense

Market segment by Type, the product can be split into
Sensors
Transmitters & Receivers
Insulin Pumps
Market segment by Application, split into
Diabetic Patients
Healthy Individuals

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Continuous Glucose Monitoring Devices status, future forecast, growth opportunity, key market and key players.
To present the Continuous Glucose Monitoring Devices development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Continuous Glucose Monitoring Devices are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Continuous Glucose Monitoring Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Continuous Glucose Monitoring Devices Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sensors
1.4.3 Transmitters & Receivers
1.4.4 Insulin Pumps
1.5 Market by Application
1.5.1 Global Continuous Glucose Monitoring Devices Market Share by Application: 2020 VS 2026
1.5.2 Diabetic Patients
1.5.3 Healthy Individuals
1.6 Coronavirus Disease 2019 (Covid-19): Continuous Glucose Monitoring Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Continuous Glucose Monitoring Devices Industry
1.6.1.1 Continuous Glucose Monitoring Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Continuous Glucose Monitoring Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Continuous Glucose Monitoring Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Continuous Glucose Monitoring Devices Market Perspective (2015-2026)
2.2 Continuous Glucose Monitoring Devices Growth Trends by Regions
2.2.1 Continuous Glucose Monitoring Devices Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Continuous Glucose Monitoring Devices Historic Market Share by Regions (2015-2020)
2.2.3 Continuous Glucose Monitoring Devices Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Continuous Glucose Monitoring Devices Market Growth Strategy
2.3.6 Primary Interviews with Key Continuous Glucose Monitoring Devices Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Continuous Glucose Monitoring Devices Players by Market Size
3.1.1 Global Top Continuous Glucose Monitoring Devices Players by Revenue (2015-2020)
3.1.2 Global Continuous Glucose Monitoring Devices Revenue Market Share by Players (2015-2020)
3.1.3 Global Continuous Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Continuous Glucose Monitoring Devices Market Concentration Ratio
3.2.1 Global Continuous Glucose Monitoring Devices Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Continuous Glucose Monitoring Devices Revenue in 2019
3.3 Continuous Glucose Monitoring Devices Key Players Head office and Area Served
3.4 Key Players Continuous Glucose Monitoring Devices Product Solution and Service
3.5 Date of Enter into Continuous Glucose Monitoring Devices Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Continuous Glucose Monitoring Devices Historic Market Size by Type (2015-2020)
4.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Type (2021-2026)

5 Continuous Glucose Monitoring Devices Breakdown Data by Application (2015-2026)
5.1 Global Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)
5.2 Global Continuous Glucose Monitoring Devices Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Continuous Glucose Monitoring Devices Market Size (2015-2020)
6.2 Continuous Glucose Monitoring Devices Key Players in North America (2019-2020)
6.3 North America Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
6.4 North America Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

7 Europe
7.1 Europe Continuous Glucose Monitoring Devices Market Size (2015-2020)
7.2 Continuous Glucose Monitoring Devices Key Players in Europe (2019-2020)
7.3 Europe Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
7.4 Europe Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

8 China
8.1 China Continuous Glucose Monitoring Devices Market Size (2015-2020)
8.2 Continuous Glucose Monitoring Devices Key Players in China (2019-2020)
8.3 China Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
8.4 China Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

9 Japan
9.1 Japan Continuous Glucose Monitoring Devices Market Size (2015-2020)
9.2 Continuous Glucose Monitoring Devices Key Players in Japan (2019-2020)
9.3 Japan Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
9.4 Japan Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Continuous Glucose Monitoring Devices Market Size (2015-2020)
10.2 Continuous Glucose Monitoring Devices Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
10.4 Southeast Asia Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

11 India
11.1 India Continuous Glucose Monitoring Devices Market Size (2015-2020)
11.2 Continuous Glucose Monitoring Devices Key Players in India (2019-2020)
11.3 India Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
11.4 India Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Continuous Glucose Monitoring Devices Market Size (2015-2020)
12.2 Continuous Glucose Monitoring Devices Key Players in Central & South America (2019-2020)
12.3 Central & South America Continuous Glucose Monitoring Devices Market Size by Type (2015-2020)
12.4 Central & South America Continuous Glucose Monitoring Devices Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Continuous Glucose Monitoring Devices Introduction
13.1.4 Abbott Laboratories Revenue in Continuous Glucose Monitoring Devices Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Echo Therapeutics, Inc.
13.2.1 Echo Therapeutics, Inc. Company Details
13.2.2 Echo Therapeutics, Inc. Business Overview and Its Total Revenue
13.2.3 Echo Therapeutics, Inc. Continuous Glucose Monitoring Devices Introduction
13.2.4 Echo Therapeutics, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.2.5 Echo Therapeutics, Inc. Recent Development
13.3 Dexcom, Inc.
13.3.1 Dexcom, Inc. Company Details
13.3.2 Dexcom, Inc. Business Overview and Its Total Revenue
13.3.3 Dexcom, Inc. Continuous Glucose Monitoring Devices Introduction
13.3.4 Dexcom, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.3.5 Dexcom, Inc. Recent Development
13.4 GlySens Incorporated
13.4.1 GlySens Incorporated Company Details
13.4.2 GlySens Incorporated Business Overview and Its Total Revenue
13.4.3 GlySens Incorporated Continuous Glucose Monitoring Devices Introduction
13.4.4 GlySens Incorporated Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.4.5 GlySens Incorporated Recent Development
13.5 Medtronic plc
13.5.1 Medtronic plc Company Details
13.5.2 Medtronic plc Business Overview and Its Total Revenue
13.5.3 Medtronic plc Continuous Glucose Monitoring Devices Introduction
13.5.4 Medtronic plc Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.5.5 Medtronic plc Recent Development
13.6 Senseonics Holdings, Inc.
13.6.1 Senseonics Holdings, Inc. Company Details
13.6.2 Senseonics Holdings, Inc. Business Overview and Its Total Revenue
13.6.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring Devices Introduction
13.6.4 Senseonics Holdings, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.6.5 Senseonics Holdings, Inc. Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview and Its Total Revenue
13.7.3 Johnson & Johnson Continuous Glucose Monitoring Devices Introduction
13.7.4 Johnson & Johnson Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 F. Hoffmann-La Roche Ltd.
13.8.1 F. Hoffmann-La Roche Ltd. Company Details
13.8.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.8.3 F. Hoffmann-La Roche Ltd. Continuous Glucose Monitoring Devices Introduction
13.8.4 F. Hoffmann-La Roche Ltd. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.8.5 F. Hoffmann-La Roche Ltd. Recent Development
13.9 AgaMatrix, Inc.
13.9.1 AgaMatrix, Inc. Company Details
13.9.2 AgaMatrix, Inc. Business Overview and Its Total Revenue
13.9.3 AgaMatrix, Inc. Continuous Glucose Monitoring Devices Introduction
13.9.4 AgaMatrix, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.9.5 AgaMatrix, Inc. Recent Development
13.10 Glucovation
13.10.1 Glucovation Company Details
13.10.2 Glucovation Business Overview and Its Total Revenue
13.10.3 Glucovation Continuous Glucose Monitoring Devices Introduction
13.10.4 Glucovation Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
13.10.5 Glucovation Recent Development
13.11 GlySure
10.11.1 GlySure Company Details
10.11.2 GlySure Business Overview and Its Total Revenue
10.11.3 GlySure Continuous Glucose Monitoring Devices Introduction
10.11.4 GlySure Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
10.11.5 GlySure Recent Development
13.12 Arkray USA, Inc.
10.12.1 Arkray USA, Inc. Company Details
10.12.2 Arkray USA, Inc. Business Overview and Its Total Revenue
10.12.3 Arkray USA, Inc. Continuous Glucose Monitoring Devices Introduction
10.12.4 Arkray USA, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
10.12.5 Arkray USA, Inc. Recent Development
13.13 OrSense
10.13.1 OrSense Company Details
10.13.2 OrSense Business Overview and Its Total Revenue
10.13.3 OrSense Continuous Glucose Monitoring Devices Introduction
10.13.4 OrSense Revenue in Continuous Glucose Monitoring Devices Business (2015-2020)
10.13.5 OrSense Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Continuous Glucose Monitoring Devices Key Market Segments

Table 2. Key Players Covered: Ranking by Continuous Glucose Monitoring Devices Revenue

Table 3. Ranking of Global Top Continuous Glucose Monitoring Devices Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Continuous Glucose Monitoring Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Sensors

Table 6. Key Players of Transmitters & Receivers

Table 7. Key Players of Insulin Pumps

Table 8. COVID-19 Impact Global Market: (Four Continuous Glucose Monitoring Devices Market Size Forecast Scenarios)

Table 9. Opportunities and Trends for Continuous Glucose Monitoring Devices Players in the COVID-19 Landscape

Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 11. Key Regions/Countries Measures against Covid-19 Impact

Table 12. Proposal for Continuous Glucose Monitoring Devices Players to Combat Covid-19 Impact

Table 13. Global Continuous Glucose Monitoring Devices Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 14. Global Continuous Glucose Monitoring Devices Market Size by Regions (US$ Million): 2020 VS 2026

Table 15. Global Continuous Glucose Monitoring Devices Market Size by Regions (2015-2020) (US$ Million)

Table 16. Global Continuous Glucose Monitoring Devices Market Share by Regions (2015-2020)

Table 17. Global Continuous Glucose Monitoring Devices Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 18. Global Continuous Glucose Monitoring Devices Market Share by Regions (2021-2026)

Table 19. Market Top Trends

Table 20. Key Drivers: Impact Analysis

Table 21. Key Challenges

Table 22. Continuous Glucose Monitoring Devices Market Growth Strategy

Table 23. Main Points Interviewed from Key Continuous Glucose Monitoring Devices Players

Table 24. Global Continuous Glucose Monitoring Devices Revenue by Players (2015-2020) (Million US$)

Table 25. Global Continuous Glucose Monitoring Devices Market Share by Players (2015-2020)

Table 26. Global Top Continuous Glucose Monitoring Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Continuous Glucose Monitoring Devices as of 2019)

Table 27. Global Continuous Glucose Monitoring Devices by Players Market Concentration Ratio (CR5 and HHI)

Table 28. Key Players Headquarters and Area Served

Table 29. Key Players Continuous Glucose Monitoring Devices Product Solution and Service

Table 30. Date of Enter into Continuous Glucose Monitoring Devices Market

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 33. Global Continuous Glucose Monitoring Devices Market Size Share by Type (2015-2020)

Table 34. Global Continuous Glucose Monitoring Devices Revenue Market Share by Type (2021-2026)

Table 35. Global Continuous Glucose Monitoring Devices Market Size Share by Application (2015-2020)

Table 36. Global Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 37. Global Continuous Glucose Monitoring Devices Market Size Share by Application (2021-2026)

Table 38. North America Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 39. North America Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 40. North America Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 41. North America Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 42. North America Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 43. North America Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 44. Europe Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 45. Europe Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 46. Europe Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 47. Europe Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 48. Europe Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 49. Europe Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 50. China Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 51. China Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 52. China Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 53. China Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 54. China Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 55. China Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 56. Japan Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 57. Japan Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 58. Japan Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 59. Japan Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 60. Japan Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 61. Japan Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 62. Southeast Asia Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 63. Southeast Asia Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 64. Southeast Asia Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 65. Southeast Asia Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 66. Southeast Asia Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 67. Southeast Asia Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 68. India Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 69. India Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 70. India Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 71. India Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 72. India Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 73. India Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 74. Central & South America Key Players Continuous Glucose Monitoring Devices Revenue (2019-2020) (Million US$)

Table 75. Central & South America Key Players Continuous Glucose Monitoring Devices Market Share (2019-2020)

Table 76. Central & South America Continuous Glucose Monitoring Devices Market Size by Type (2015-2020) (Million US$)

Table 77. Central & South America Continuous Glucose Monitoring Devices Market Share by Type (2015-2020)

Table 78. Central & South America Continuous Glucose Monitoring Devices Market Size by Application (2015-2020) (Million US$)

Table 79. Central & South America Continuous Glucose Monitoring Devices Market Share by Application (2015-2020)

Table 80. Abbott Laboratories Company Details

Table 81. Abbott Laboratories Business Overview

Table 82. Abbott Laboratories Product

Table 83. Abbott Laboratories Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 84. Abbott Laboratories Recent Development

Table 85. Echo Therapeutics, Inc. Company Details

Table 86. Echo Therapeutics, Inc. Business Overview

Table 87. Echo Therapeutics, Inc. Product

Table 88. Echo Therapeutics, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 89. Echo Therapeutics, Inc. Recent Development

Table 90. Dexcom, Inc. Company Details

Table 91. Dexcom, Inc. Business Overview

Table 92. Dexcom, Inc. Product

Table 93. Dexcom, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 94. Dexcom, Inc. Recent Development

Table 95. GlySens Incorporated Company Details

Table 96. GlySens Incorporated Business Overview

Table 97. GlySens Incorporated Product

Table 98. GlySens Incorporated Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 99. GlySens Incorporated Recent Development

Table 100. Medtronic plc Company Details

Table 101. Medtronic plc Business Overview

Table 102. Medtronic plc Product

Table 103. Medtronic plc Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 104. Medtronic plc Recent Development

Table 105. Senseonics Holdings, Inc. Company Details

Table 106. Senseonics Holdings, Inc. Business Overview

Table 107. Senseonics Holdings, Inc. Product

Table 108. Senseonics Holdings, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 109. Senseonics Holdings, Inc. Recent Development

Table 110. Johnson & Johnson Company Details

Table 111. Johnson & Johnson Business Overview

Table 112. Johnson & Johnson Product

Table 113. Johnson & Johnson Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 114. Johnson & Johnson Recent Development

Table 115. F. Hoffmann-La Roche Ltd. Business Overview

Table 116. F. Hoffmann-La Roche Ltd. Product

Table 117. F. Hoffmann-La Roche Ltd. Company Details

Table 118. F. Hoffmann-La Roche Ltd. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 119. F. Hoffmann-La Roche Ltd. Recent Development

Table 120. AgaMatrix, Inc. Company Details

Table 121. AgaMatrix, Inc. Business Overview

Table 122. AgaMatrix, Inc. Product

Table 123. AgaMatrix, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 124. AgaMatrix, Inc. Recent Development

Table 125. Glucovation Company Details

Table 126. Glucovation Business Overview

Table 127. Glucovation Product

Table 128. Glucovation Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 129. Glucovation Recent Development

Table 130. GlySure Company Details

Table 131. GlySure Business Overview

Table 132. GlySure Product

Table 133. GlySure Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 134. GlySure Recent Development

Table 135. Arkray USA, Inc. Company Details

Table 136. Arkray USA, Inc. Business Overview

Table 137. Arkray USA, Inc. Product

Table 138. Arkray USA, Inc. Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 139. Arkray USA, Inc. Recent Development

Table 140. OrSense Company Details

Table 141. OrSense Business Overview

Table 142. OrSense Product

Table 143. OrSense Revenue in Continuous Glucose Monitoring Devices Business (2015-2020) (Million US$)

Table 144. OrSense Recent Development

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Continuous Glucose Monitoring Devices Market Share by Type: 2020 VS 2026

Figure 2. Sensors Features

Figure 3. Transmitters & Receivers Features

Figure 4. Insulin Pumps Features

Figure 5. Global Continuous Glucose Monitoring Devices Market Share by Application: 2020 VS 2026

Figure 6. Diabetic Patients Case Studies

Figure 7. Healthy Individuals Case Studies

Figure 8. Continuous Glucose Monitoring Devices Report Years Considered

Figure 9. Global Continuous Glucose Monitoring Devices Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global Continuous Glucose Monitoring Devices Market Share by Regions: 2020 VS 2026

Figure 11. Global Continuous Glucose Monitoring Devices Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global Continuous Glucose Monitoring Devices Market Share by Players in 2019

Figure 14. Global Top Continuous Glucose Monitoring Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Continuous Glucose Monitoring Devices as of 2019

Figure 15. The Top 10 and 5 Players Market Share by Continuous Glucose Monitoring Devices Revenue in 2019

Figure 16. North America Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central & South America Continuous Glucose Monitoring Devices Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 24. Abbott Laboratories Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 25. Echo Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 26. Echo Therapeutics, Inc. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 27. Dexcom, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Dexcom, Inc. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 29. GlySens Incorporated Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. GlySens Incorporated Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 31. Medtronic plc Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Medtronic plc Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 33. Senseonics Holdings, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Senseonics Holdings, Inc. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 35. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Johnson & Johnson Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 37. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 39. AgaMatrix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. AgaMatrix, Inc. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 41. Glucovation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Glucovation Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 43. GlySure Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. GlySure Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 45. Arkray USA, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. Arkray USA, Inc. Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 47. OrSense Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. OrSense Revenue Growth Rate in Continuous Glucose Monitoring Devices Business (2015-2020)

Figure 49. Bottom-up and Top-down Approaches for This Report

Figure 50. Data Triangulation

Figure 51. Key Executives Interviewed

Abbott Laboratories

Echo Therapeutics, Inc.

Dexcom, Inc.

GlySens Incorporated

Medtronic plc

Senseonics Holdings, Inc.

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

AgaMatrix, Inc.

Glucovation

GlySure

Arkray USA, Inc.

OrSense

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3003

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase